235 results on '"McColgan, Peter"'
Search Results
2. Anti-amphiphysin associated paraneoplastic diencephalitis secondary to a thymic neuroendocrine tumour
3. Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
4. Structural brain network degeneration and functional up-regulation in Huntington's disease
5. Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
6. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis
7. Plasma and CSF neurofilament light chain are stabilized in response to mutant huntingtin lowering in the brain of Huntington disease mice
8. Neuroimaging and plasma evidence of early white matter loss in Parkinson’s disease with poor outcomes
9. Dementia risk in Parkinson’s disease is associated with interhemispheric connectivity loss and determined by regional gene expression
10. The human motor cortex microcircuit: insights for neurodegenerative disease
11. Modeling disease progression and placebo response in Huntington's Disease: Insights from Enroll-HD and GENERATION HD1 cohorts
12. Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease
13. NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysis.
14. Reformvorschläge zur Organspende - Die Widerspruchslösung auf dem Prüfstand
15. Brain Regions Showing White Matter Loss in Huntington’s Disease Are Enriched for Synaptic and Metabolic Genes
16. Tominersen in Adults with Manifest Huntington’s Disease
17. Abschied vom Informationsmodell im Recht allgemeiner Geschäftsbedingungen
18. Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction
19. Neuroimaging and plasma marker evidence for white matter macrostructure loss in Parkinson’s disease
20. Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
21. Reply to ‘Topographical layer imaging as a tool to track neurodegenerative disease spread in M1’
22. Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis
23. Anti-amphiphysin associated paraneoplastic diencephalitis secondary to a thymic neuroendocrine tumour
24. 1609 Length of white matter connexions determine their rate of atrophy in premanifest huntington’s disease
25. Reply: MRI findings of visual system alterations in Parkinson’s disease
26. J02 Quantitative analyses of pooled tominersen clinical data to support dose selection (rationale) for the new phase II study
27. J04 Benchmarking enroll-HD to a phase III placebo cohort from generation HD1 to inform clinical trial planning
28. E10 Cross-sectional exploration of the clinical utility of brain age as an imaging-based marker of disease pathology in Huntington’s disease (HD) based on the tominersen phase III trial generation HD 1
29. J03 Evaluating tominersen effect on self-reported quality of life (QoL) with high-frequency longitudinal, digital euroqol 5-dimensions 5-level (EQ-5D-5L) survey in generation HD1, a phase III trial of tominersen in adult individuals with manifest Huntington’s disease (HD)
30. E09 Quantitative MRI profiles across motor cortex cortical layers in premanifest Huntington’s disease using 7T MRI at 600μm resolution
31. Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis
32. Neurofilament light-associated connectivity in young-adult Huntington’s disease is related to neuronal genes
33. 121 Autoimmune autonomic neuropathy on the Adie spectrum: ‘Ross syndrome?’
34. 128 White matter fibre loss in Parkinson’s disease hallucinations
35. 129 Network controllability and regional gene expression explain visual hallucinations in Parkinson’s
36. Visual dysfunction predicts cognitive impairment and white matter degenera- tion in Parkinson’s disease
37. Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis.
38. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington’s disease
39. Basal ganglia-cortical structural connectivity in Huntingtonʼs disease
40. Stem Cell Tracking in Human Trials: A Meta-Regression
41. Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson’s disease
42. F05 Biological and clinical characteristics of gene carriers far from predicted onset in the hd-yas study: a cross-sectional analysis
43. Relating quantitative 7T MRI across cortical depths to cytoarchitectonics, gene expression and connectomics
44. Can neuroimaging predict dementia in Parkinson’s disease?
45. Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
46. QUALITY IMPROVEMENT PROJECT: DETECTING, INSTIGATING AND ASSESSING EFFECTIVE HANDOVER TECHNIQUES
47. The Addenbrookeʼs Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
48. Addenbrookeʼs Cognitive Examination-Revised for mild cognitive impairment in Parkinsonʼs disease
49. Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review
50. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.